Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness

Yael Aschner1, Anthony P Khalifah1, Natalie Briones2

  • 1Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado, Aurora, Colorado.

Insights

Receptor type protein tyrosine phosphatase alpha (PTP-α) plays a key role in pulmonary fibrosis. Genetic deletion of PTP-α protected mice from lung fibrosis by reducing fibroblast responsiveness to TGF-β.

Area of Science:

  • Cell Biology
  • Pulmonary Medicine
  • Biochemistry

Background:

  • Fibrotic lung diseases are progressive and fatal with limited treatments.
  • Receptor type protein tyrosine phosphatase alpha (PTP-α) is a key regulator of fibroblast signaling.
  • PTP-α influences cellular responses to growth factors and cytokine signaling.

Purpose of the Study:

  • To investigate the direct role of PTP-α in the pathogenesis of pulmonary fibrosis.
  • To determine if PTP-α deficiency protects against induced lung fibrosis.
  • To elucidate the mechanism by which PTP-α influences fibroblast profibrotic activity.

Main Methods:

  • Pulmonary fibrosis was induced in wild-type and PTP-α deficient (Ptpra(-/-)) mice using bleomycin or TGF-β1.
  • Bone marrow chimera experiments were performed to identify the cell type responsible for protection.
  • Profibrotic responses were compared in wild-type and Ptpra(-/-) mouse embryonic and lung fibroblasts.
  • TGF-β-induced gene expression and Smad2/3 transcriptional activity were assessed.

Main Results:

  • Ptpra(-/-) mice were protected from bleomycin- and TGF-β1-induced pulmonary fibrosis.
  • Protection was attributed to lung parenchymal cells, not bone marrow-derived cells.
  • Ptpra(-/-) fibroblasts showed hyporesponsiveness to TGF-β, with diminished expression of αSMA, EDA-fibronectin, collagen 1A, and CTGF.
  • TGF-β-induced Smad2/3 transcriptional activity was markedly attenuated in Ptpra(-/-) fibroblasts.

Conclusions:

  • PTP-α is a critical mediator of profibrotic signaling in lung fibroblasts.
  • PTP-α promotes pulmonary fibrosis by regulating fibroblast responsiveness to TGF-β.
  • Targeting PTP-α may offer a therapeutic strategy for fibrotic lung diseases.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K